Pharmacokinetic analysis is essential in the drug development process, informing dosage regimen design and safety assessments. This book offers a comprehensive guide to pharmacokinetic analysis techniques, including compartmental and non-compartmental models, population pharmacokinetics, and physiologically-based pharmacokinetic (PBPK) modeling. It covers the application of pharmacokinetic principles in preclinical and clinical studies, regulatory considerations, and the integration of pharmacokinetic data into drug development pipelines. Aimed at pharmaceutical scientists, pharmacometricians, and regulatory professionals, the book provides practical tools and methodologies for effective pharmacokinetic analysis in drug development.
Aiden Reynolds is an expert dermatologist specializing in pharmacokinetic analysis within drug development, focusing on assessing how dermatological medications are absorbed, distributed, metabolized, and excreted during the development process. His research investigates the pharmacokinetic profiles of new dermatological drugs, optimizing their formulation, dosing, and delivery methods to enhance efficacy and minimize adverse effects. Aiden has published extensively on the methodologies and best practices for conducting pharmacokinetic studies in dermatological drug development, ensuring robust and reliable data to inform clinical use. He has developed comprehensive pharmacokinetic analysis protocols that enhance the development and application of new dermatological medications. He also offers valuable insights and guidelines for researchers and clinicians involved in drug development, promoting the creation of safe and effective dermatological therapies through comprehensive pharmacokinetic analysis.